Brendel Financial Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
DG
Brendel Financial Advisors's HCAT Position: Q1 2024 in Review
Brendel Financial Advisors sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 11,831 shares — an estimated $110K sold.
Brendel Financial Advisors first reported a position in HCAT in Q2 2023 and held it in 3 quarters. The position peaked at $149K in Q2 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.
- Brendel Financial Advisors reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
- Brendel Financial Advisors sold 11,831 Health Catalyst shares in Q1 2024, an estimated $110K.
- Brendel Financial Advisors first reported a position in Health Catalyst in Q2 2023 and held it in 3 quarters.
- Brendel Financial Advisors's Health Catalyst position peaked at $149K in Q2 2023.
- 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.
Based on Brendel Financial Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.